Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia
T Refaï, A Millier, C Rémuzat, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries
A Millier, S Aballea, M Toumi, et al.
Journal of Medical Economics
|
September 12, 2014
Utility decrements associated with side effects in schizophrenia
A Millier, I Amri, L Boyer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia
A Millier, K Siegrist, I Amri, et al.
Journal of Market Access & Health Policy
|
October 31, 2017
Healthcare resource use in schizophrenia, EuroSC findings
A Millier, M Horváth, F Ma, et al.
Journal of Medical Economics
|
November 9, 2021
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
J A Spoorendonk, J-B Briere, K Bowrin, et al.
Journal of Psychiatric Research
|
May 6, 2014
Humanistic burden in schizophrenia: a literature review
A Millier, U Schmidt, M C Angermeyer, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 12, 2018
Direct healthcare cost of schizophrenia - European overview
G Kovács, T Almási, A Millier, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia
T Refaï, A Millier, C Rémuzat, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries
A Millier, S Aballea, M Toumi, et al.
Journal of Medical Economics
|
September 12, 2014
Utility decrements associated with side effects in schizophrenia
A Millier, I Amri, L Boyer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia
A Millier, K Siegrist, I Amri, et al.
Journal of Market Access & Health Policy
|
October 31, 2017
Healthcare resource use in schizophrenia, EuroSC findings
A Millier, M Horváth, F Ma, et al.
Journal of Medical Economics
|
November 9, 2021
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
J A Spoorendonk, J-B Briere, K Bowrin, et al.
Journal of Psychiatric Research
|
May 6, 2014
Humanistic burden in schizophrenia: a literature review
A Millier, U Schmidt, M C Angermeyer, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 12, 2018
Direct healthcare cost of schizophrenia - European overview
G Kovács, T Almási, A Millier, et al.
Page
of 2